Gul Ghuttai Khalid

ORCID: 0000-0002-7767-288X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Global Maternal and Child Health
  • Cardiac Arrest and Resuscitation
  • Mechanical Circulatory Support Devices
  • Neonatal Respiratory Health Research
  • Acute Myocardial Infarction Research
  • Infant Development and Preterm Care
  • Urinary Tract Infections Management

Médecins Sans Frontières
2017-2020

Frontier Medical College
2020

University of Bangui
2017

The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global incidence by 80% 2030, but little is known about how this reduction could be achieved the costs of doing so. We aimed evaluate effects cost different strategies scale in Pakistan determine what required meet targets incidence.

10.1016/s2214-109x(20)30003-6 article EN cc-by-nc-nd The Lancet Global Health 2020-02-19

The burden of hepatitis C (HCV) infection in Pakistan is among the highest world, with a reported national HCV prevalence 6.7% 2014. In specific populations, such as urban communities Karachi, suspected to be higher. Interferon-free treatment for chronic (CHC) could allow scale up, simplification and decentralization communities. We present an interim analysis over course February-December 2015 interferon-free, decentralised CHC programme community clinic Machar Colony, Pakistan.A...

10.1371/journal.pone.0175562 article EN cc-by PLoS ONE 2017-04-27

Abstract Background In the high-prevalence setting of Pakistan, screening, diagnosis and treatment services for chronic hepatitis C (CHC) patients are commonly offered in specialized facilities. We aimed to describe cascade care a Médecins Sans Frontières primary health clinic offering CHC an informal settlement Karachi, Pakistan. Methods This was retrospective cohort analysis using routinely collected data. Three different screening algorithms were assessed among with one or more risk...

10.1093/inthealth/ihy096 article EN cc-by-nc International Health 2018-11-30

Despite the availability of effective direct-acting antiviral (DAA) treatments for Hepatitis C virus (HCV) infection, many people remain undiagnosed and untreated. We assessed cost-effectiveness a Médecins Sans Frontières (MSF) HCV screening treatment programme within primary health clinic in Karachi, Pakistan. A state transition Markov model was developed to estimate MSF programme. Programme cost outcome data were analysed retrospectively. The incremental ratio (ICER) calculated terms (2016...

10.1111/jvh.13422 article EN cc-by Journal of Viral Hepatitis 2020-10-14

Setting: Although neonatal mortality is gradually decreasing worldwide, 98% of deaths occur in low-and middle-income countries, where hospital care for sick and premature neonates often unavailable.Médecins Sans Frontières Operational Centre Brussels (MSF-OCB) managed eight specialised units (SN-CUs) at district level low-resource conflict-affected settings seven countries.Objective: To assess the performance MSF SNCU model across different Africa Southern Asia, to describe set-up SNCUs,...

10.5588/pha.16.0127 article EN cc-by Public Health Action 2017-06-21
Coming Soon ...